SPN-812
812P413
Approved small_molecule active
Quick answer
SPN-812 for Attention-Deficit/Hyperactivity Disorder is a Approved program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 3 ClinicalTrials.gov record(s).
Program details
- Company
- SUPERNUS PHARMACEUTICALS, INC.
- Indication
- Attention-Deficit/Hyperactivity Disorder
- Phase
- Approved
- Modality
- small_molecule
- Status
- active